Drug interaction (19. combination with antiparkinson agents)
نویسندگان
چکیده
منابع مشابه
Sustained release antiparkinson agents: controlled release levodopa.
The rationale for sustained release oral levodopa preparations is to deliver levodopa in the areas of maximal intestinal absorption in a slow and predictable way, leading to stable plasma levodopa levels and brain dopamine levels, therefore resulting in a lengthened duration of action. Sinemet CR is the prototype of such preparations, with demonstrated efficacy in decreasing periods of akinesia...
متن کامل„Pregnancy in Parkinson ́s disease: fetal outcome under antiparkinson-agents”
conclusion 1Department of Gynecology & Obstetrics, Helios Hanseklinikum Stralsund, Germany 2IDepartment of Neurology, Helios Hanseklinikum Stralsund, Germany A literature review (Fig.1) and case report . Abstract objective Abstract methods A 33-year-old woman (4G/3P) with a 5-year history of parkinsonism became pregnant being on highly dosed antiparkinson-agents (Ropinirol 24 mg, Rasagilin 1 mg...
متن کاملQuantum chemical study of Interaction of PLGA polymeric nanoparticles as drug delivery with anti-cancer agents of thiazoline
Thiazoles derivatives are consisted in chemical compounds such as antimicrobial and anticancer medicine. Since polylactic-co-glycolic acid (PLGA) polymeric nanoparticles has been conversed about nanomedicine applications and particularly as drug delivery systems. Because of molecular self-assemblies and biodegradability of PLGA polymer, it can be used to carry anti-cancer and antimicrobial drug...
متن کاملAntiparkinson prodrugs.
Parkinson's disease (PD) is a progressive, neurodegenerative disorder which involves the loss of dopaminergic neurons of the substantia nigra pars compacta. Current therapy is essentially symptomatic, and L-Dopa (LD), the direct precursor of dopamine(DA), is the treatment of choice in more advanced stages of the disease. Substitution therapy with LD is, however, associated with a number of acut...
متن کاملImpact of insufficient drug efficacy of antiparkinson agents on patient’s quality of life: a cross-sectional study
BACKGROUND To understand the current state of insufficient drug efficacy experienced by patients with Parkinson's disease (PD) and its effects on quality of life (QOL), we conducted a survey of patients with PD and analyzed the results from 2,630 completed questionnaires. METHODS The questionnaires inquired about age, sex, Hoehn and Yahr stage, disease duration, drugs currently being taken, a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
سال: 2010
ISSN: 0030-1558,1882-4528
DOI: 10.4044/joma.122.259